ORKA
ORKA news
Latest 3 stories · newest Sep 23, 2026
ORKA
Oruka Therapeutics Q2 Financial Results & Updates on ORKA-001 & ORKA-002 Programs
Oruka Therapeutics reported Q2 financial results and updated clinical pipelines, advancing multiple programs with key data readouts expected in late 2026 and 2027.
ORKA
Oruka amends IL-23 license agreement with Paragon expanding field to all therapeutic areas
Oruka Therapeutics and Paragon Therapeutics executed a first amendment to their IL-23 license agreement dated May 29, 2026, expanding the Field definition from inflammatory bowel disease to all therapeutic areas. The amendment broadens Oruka's development rights and commercial opportunities for IL-2…
BriefTape provides AI-summarized public SEC filings for informational purposes only. Content does not constitute investment advice. Always verify against source filings at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.
The same ORKA feed as JSON for your bot or app:
GET https://api.brieftape.com/v1/tickers/ORKA/newsSTART FREE